Innovating Works

20MED

Desconocido
CARTHAGO: Cartilaginous tissue regeneration by non viral gene therapy taking the hurdles towards efficient de... 20MED THERAPEUTICS BV participó en un H2020: H2020-MSCA-ITN-2020 Chronic low back pain due to intervertebral disc (IVD) degeneration and osteoarthritis (OA) worldwide impact human health and well-being due...
2020-09-02 - 2024-08-31 | Financiado
StarT: European Training Network to Diagnose Understand and Treat Stargardt Disease a Frequent Inherited... 20MED THERAPEUTICS BV participó en un H2020: H2020-MSCA-ITN-2018 StarT will create an interdisciplinary and intersectorial European training network focusing on different aspects of autosomal recessive Sta...
2018-08-30 - 2023-03-31 | Financiado
B-SMART: Brain Specific Modular and Active RNA Therapeutics 20MED THERAPEUTICS BV participó en un H2020: H2020-NMBP-2016-2017 The overall objective of B-SMART is: 1. to design modular nanoparticles, 2. to manufacture them via a quality-by-design protocol, 3. to achi...
2016-11-09 - 2022-06-30 | Financiado
OcuTher: Educational Network in Ocular Drug Delivery and Therapeutics 20MED THERAPEUTICS BV participó en un H2020: H2020-MSCA-ITN-2016 Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big...
2016-08-16 - 2020-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.